Qiagen NVXTER:QIA +4.28%69 OCF Margin % is 20.44% as of Mar. 2026, which is 18% below its 10-year median of 25.01. GuruFocus rates XTER:QIA with a GF Score™ of 69/100 and a GF Value™ of €46.28 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Qiagen NV ranks better than 91.67% on this metric.
The historical rank and industry rank for Qiagen NV's OCF Margin % or its related term are showing as below:
XTER:QIA'
s OCF Margin % Range Over the Past 10 Years
Min: 20.23 Med: 25.01 Max: 34.05
Current: 29.29
During the past 13 years, the highest OCF Margin % of Qiagen NV was 34.05%. The lowest was 20.23%. And the median was 25.01%.
XTER:QIA's OCF Margin % is ranked better than 91.67% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs XTER:QIA: 29.29
Qiagen NV OCF Margin % Related Terms
Qiagen NV OCF Margin % Historical Data
* Premium members only.
The historical data trend for Qiagen NV's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:QIA vs CRL, ICLR, BLLN: OCF Margin % Comparison
For the Diagnostics & Research subindustry, Qiagen NV's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qiagen NV OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Qiagen NV's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qiagen NV (XTER:QIA) has a OCF Margin % of 20.44% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Qiagen NV and its competitors. This is 18% below median its historical median of 25.01. Over the past decade, Qiagen NV's OCF Margin % has ranged from 20.23 to 34.05. According to the industry distribution chart, Qiagen NV ranks #17 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 8.3%.
Is Qiagen NV's OCF Margin % too high?
Qiagen NV's current OCF Margin % of 20.44% is 18% below median its 10-year median of 25.01. Over the past 10 years, this metric has ranged from a low of 20.23 to a high of 34.05. The Medical Diagnostics & Research industry median OCF Margin % is 4.76. Qiagen NV's value of 20.44% is 329.9% above this industry median. Based on the distribution chart, Qiagen NV ranks #17 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Qiagen NV has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qiagen NV's OCF Margin % compare to CRL and ICLR?
According to the Medical Diagnostics & Research industry distribution chart, Qiagen NV ranks #17 out of 204 companies for OCF Margin %. This places Qiagen NV in the top 8% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 4.76. Qiagen NV's value of 20.44% is 329.9% above this benchmark. Historically, Qiagen NV's own OCF Margin % has ranged from 20.23 to 34.05 over the past decade. While the company's 10-year median is 25.01 vs. the industry median of 4.76, Qiagen NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qiagen NV's current OCF Margin % of 20.44% is 329.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Qiagen NV and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qiagen NV's current OCF Margin % is 20.44%, which is 18% below median its own 10-year median of 25.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qiagen NV stock overvalued right now?
Based on GuruFocus' analysis, Qiagen NV (XTER:QIA) is currently considered Modestly Undervalued. The stock's GF Value™ is €46.28, compared to a current price of €34.01 — trading 26.5% below its estimated fair value. The current OCF Margin % is 20.44%, which is 18% below median its 10-year median of 25.01 and 329.9% above the Medical Diagnostics & Research industry median of 4.76. Qiagen NV's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Qiagen NV (XTER:QIA), the current OCF Margin % is 20.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qiagen NV (XTER:QIA) Overvalued in 2026?
Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued.
The current stock price of €34.01 is trading 26.5% below its estimated GF Value™ of €46.28.
GuruFocus considers Qiagen NV to be Modestly Undervalued.
Key valuation signals for XTER:QIA:
OCF Margin %: 20.44% (18% below median its 10-year median of 25.01)
GF Value™: €46.28 vs. price of €34.01 (26.5% below fair value)
Industry Position: 329.9% above the Medical Diagnostics & Research median (#17 of 204)
No single metric tells the full story. See the XTER:QIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
69GF Score
Get the complete analysis for XTER:QIA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:QIA has been successfully added to your 
